Status | Study |
Recruiting |
Study Name: Hyperion™ International Registry Trial Condition: Atrial Septal Defects Patent Ductus Arteriosus Date: 2014-08-14 Interventions: Device: ASD and PDA closure |
Recruiting |
Study Name: Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect Condition: Atrial Septal Defect Successful Device Closure Date: 2014-03-25 Interventions: Device: Transcatheter device closure Closure of atrial sep |
Active, not recruiting |
Study Name: FIH Study With CBSO Condition: Atrial Septal Defect (ASD) Patent Foramen Ovale (PFO) Date: 2013-10-08 Interventions: Device: Device Closure of Atrial Septal Defect Device Closure of Atrial Septal Defect by "Carag Bio |
Completed |
Study Name: Fluid Balance During Closure of Atrial Septal Defect Condition: Heart Defects,Congenital Heart Septal Defects, Atrial Date: 2012-12-21 |
Active, not recruiting |
Study Name: Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects Condition: Septal Defect, Atrial Date: 2012-10-11 Interventions: Device: GORE® Septal Occluder The GORE® Septal Occluder consists of an implantable occluder an |
Completed |
Study Name: Bosentan for Mild Pulmonary Vascular Disease in Asd Patients. Condition: Heart Septal Defects, Atrial Date: 2010-10-08 Interventions: Drug: Bosentan Treatment will |
Recruiting |
Study Name: Study of Blood Clotting After Transcatheter Atrial Septal Defect Closure Condition: Thrombosis Date: 2010-03-08 Interventions: Drug: Low molecular weight heparin Low molecular weight he |
Completed |
Study Name: Procedural Success and Safety of the Nit-Occlud® Patent Foramen Ovale (PFO) Closure Device and Its Application System Condition: Foramen Ovale, Patent Heart Catheterization Date: 2009-08-27 Interventions: Device: Nit-Occlud® PFO Transcatheter implantation of a PFO occluder (Nitinol double Umbrella) |
Active, not recruiting |
Study Name: Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects Condition: Migraine Date: 2008-11-26 Interventions: Drug: Clopidogrel Patients will be randomized either to aspirin (80 mg/day) or aspirin (80 mg/day) + clo |
Recruiting |
Study Name: Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study Condition: Atrial Septal Defect Date: 2008-03-31 Interventions: Device: AMPLATZER Septal Occluder AMPLATZER Septal Occluder |